These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17617208)

  • 1. Small molecule and novel treatments for chronic hepatitis C virus infection.
    Harrison SA
    Am J Gastroenterol; 2007 Oct; 102(10):2332-8. PubMed ID: 17617208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs).
    Kieffer TL; Kwong AD; Picchio GR
    J Antimicrob Chemother; 2010 Feb; 65(2):202-12. PubMed ID: 19903720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telaprevir: hope on the horizon, getting closer.
    Weisberg IS; Jacobson IM
    Clin Liver Dis; 2009 Aug; 13(3):441-52. PubMed ID: 19628160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future treatment of chronic hepatitis C.
    Keeffe EB
    Antivir Ther; 2007; 12(7):1015-25. PubMed ID: 18018759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future directions in therapy for chronic hepatitis C.
    Jensen DM; Ascione A
    Antivir Ther; 2008; 13 Suppl 1():31-6. PubMed ID: 18432161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapies for hepatitis C virus infection.
    Soriano V; Peters MG; Zeuzem S
    Clin Infect Dis; 2009 Feb; 48(3):313-20. PubMed ID: 19123867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future management of chronic hepatitis C infection.
    Cross TJ; Antoniades CG; Harrison PM
    Postgrad Med J; 2008 Apr; 84(990):172-6. PubMed ID: 18424572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral therapy: chronic hepatitis C.
    Heathcote EJ
    J Viral Hepat; 2007 Nov; 14 Suppl 1():82-8. PubMed ID: 17958648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine protease inhibitors as anti-hepatitis C virus agents.
    Reiser M; Timm J
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibitors of hepatitis C virus replication.
    Neyts J
    Antiviral Res; 2006 Sep; 71(2-3):363-71. PubMed ID: 16843538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future therapy of hepatitis C.
    McHutchison JG; Patel K
    Hepatology; 2002 Nov; 36(5 Suppl 1):S245-52. PubMed ID: 12407600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: investigational agents for chronic hepatitis C.
    Thompson AJ; McHutchison JG
    Aliment Pharmacol Ther; 2009 Apr; 29(7):689-705. PubMed ID: 19183149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide prodrugs for the treatment of HCV infection.
    Sofia MJ
    Adv Pharmacol; 2013; 67():39-73. PubMed ID: 23885998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and development of small molecule HCV antivirals.
    Ni ZJ; Wagman AS
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):446-59. PubMed ID: 15338954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural products and chronic hepatitis C virus.
    Azzam HS; Goertz C; Fritts M; Jonas WB
    Liver Int; 2007 Feb; 27(1):17-25. PubMed ID: 17241377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HCV p7 as a therapeutic target.
    Griffin S
    Curr Opin Investig Drugs; 2010 Feb; 11(2):175-81. PubMed ID: 20112167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel delivery methods for treatment of viral hepatitis: an update.
    Virovic L; Wu CH; Konishi M; Wu GY
    Expert Opin Drug Deliv; 2005 Jul; 2(4):707-17. PubMed ID: 16296795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection treatment: An era of game changer direct acting antivirals and novel treatment strategies.
    Shahid I; ALMalki WH; Hafeez MH; Hassan S
    Crit Rev Microbiol; 2016 Aug; 42(4):535-47. PubMed ID: 25373616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New antivirals against hepatitis C virus(protease inhibitors, polymerase inhibitors, and host factor targeting antivirals)].
    Kato N; Muroyama R
    Nihon Rinsho; 2011 May; 69 Suppl 4():275-81. PubMed ID: 22096931
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific targeted antiviral therapy for hepatitis C.
    Sulkowski MS
    Curr Gastroenterol Rep; 2007 Mar; 9(1):5-13. PubMed ID: 17335672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.